statements

Riddhi Siddhi Gluco Biols Ltd.

BSE: 524480

Sector: Services

Industry Group: Commercial Services & Supplies

Industry: Trading & Distributors

650.00-10.1 (-1.53%)

23 Oct, 10:29 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Riddhi Siddhi Gluco Biols Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	C 2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	23.70	475.45	486.04	45.58	342.00	508.08	803.96	681.81	576.30	497.65	223.30	172.93	267.98	135.51	235.84	171.11
Cost of Operating Revenue	36.69	479.18	489.78	46.20	266.54	358.29	664.81	514.64	471.39	491.68	189.33	158.20	242.10	112.52	221.31	153.38
Gross Profit	-12.99	-3.72	-3.74	-0.62	75.46	149.79	139.15	167.18	104.91	5.97	33.96	14.73	25.88	22.99	14.53	17.73
Gross Margin	-54.8	-0.8	-0.8	-1.4	22.1	29.5	17.3	24.5	18.2	1.2	15.2	8.5	9.7	17.0	6.2	10.4
Total Operating Expenses	37.25	482.97	496.90	54.71	377.56	590.02	848.67	612.37	565.23	548.75	211.48	183.84	272.82	141.06	256.05	194.28
Operating Profit	-13.55	-7.52	-10.86	-9.13	-35.56	-81.94	-44.71	69.44	11.06	-51.10	11.82	-10.90	-4.85	-5.55	-20.21	-23.17
Operating Margin	-57.2	-1.6	-2.2	-20.0	-10.4	-16.1	-5.6	10.2	1.9	-10.3	5.3	-6.3	-1.8	-4.1	-8.6	-13.5
Financing Income/(Expense) - Net	-25.66	24.62	15.29	-8.87	-32.99	-50.04	-61.87	-12.61	6.22	20.70	49.22	58.71	62.96	71.22	39.06	-20.02
Profit before Taxes	-39.21	28.70	5.54	29.84	59.06	-20.58	-30.12	72.91	30.24	-18.09	64.27	48.44	64.71	71.48	30.54	21.23
Income Taxes	13.37	5.99	0.86	27.27	15.17	24.73	-38.99	5.66	6.16	43.72	15.55	15.05	7.52	8.43	10.15	6.61
Profit after Tax	57.62	22.71	4.68	2.56	40.16	-42.79	18.96	48.73	32.88	-46.78	14.32	-55.54	46.70	5.20	-4.48	-9.49
PAT Margin	243.1	4.8	1.0	5.6	11.7	-8.4	2.4	7.1	5.7	-9.4	6.4	-32.1	17.4	3.8	-1.9	-5.5
EPS - Basic - ex Extraordinary Items	-51.46	23.48	4.45	2.52	56.32	-60.02	26.59	68.35	46.11	-65.62	68.85	46.15	79.47	86.17	27.92	18.85
EPS - Diluted - ex Extraordinary Items	-51.46	23.48	4.45	2.52	56.32	-60.02	26.59	68.35	46.11	-65.62	68.85	46.15	79.47	86.17	27.92	18.85
EBIT	-13.55	-7.52	-10.86	-9.13	-35.56	-81.94	-44.71	69.44	11.06	-51.10	11.82	-10.90	-4.85	-5.55	-20.21	-23.17
EBITDA	23.50	21.17	13.70	7.86	-7.12	-47.10	-10.47	104.12	47.62	-13.62	48.69	0.83	5.90	2.97	-11.98	-14.69
EBITDA Margin	99.2	4.5	2.8	17.2	-2.1	-9.3	-1.3	15.3	8.3	-2.7	21.8	0.5	2.2	2.2	-5.1	-8.6

Balance Sheet

Abridged

Understanding Balance Sheet

Riddhi Siddhi Gluco Biols Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	R 2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	C 2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	C 2012 Mar 31	R 2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	C 2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	1,310	1,032	1,028	948	1,123	1,347	1,070	935	983	600	539	490	454	464	592
Long-Term Investments	0	39	32	45	158	222	297	28	27	31	25	26	23	39	380
Property Plant & Equipment - Net	194	166	142	114	785	770	759	779	813	770	738	392	382	434	426
Total Non-Current Assets	195	216	187	173	952	1,026	1,073	1,144	1,007	1,341	1,298	1,202	1,319	1,321	1,299
Total Assets	1,505	1,247	1,215	1,121	2,075	2,373	2,143	2,078	1,991	1,941	1,838	1,692	1,774	1,784	1,891
Total Current Liabilities	347	89	70	88	347	640	416	357	340	292	156	96	92	119	146
Long Term Debt	135	120	111	92	226	189	165	116	86	81	73	1	2	1	167
Total Non-Current Liabilities	148	137	122	116	254	232	170	121	93	96	90	107	90	79	206
Total Liabilities	495	226	192	204	601	872	586	478	433	388	246	202	182	198	352
Total Shareholders' Equity	1,010	1,021	1,022	916	1,367	1,323	1,389	1,436	1,425	1,453	1,504	1,432	1,537	1,549	1,509
Minority Interest	-	-	-	-	107	178	168	165	133	99	87	58	55	38	30
Total Equity	1,010	1,021	1,022	916	1,474	1,501	1,557	1,601	1,558	1,552	1,592	1,490	1,592	1,587	1,539
Total Liabilities & Equity	1,505	1,247	1,215	1,121	2,075	2,373	2,143	2,078	1,991	1,941	1,838	1,692	1,774	1,784	1,891

Cash Flow

Abridged

Understanding Cash Flow Statement

Riddhi Siddhi Gluco Biols Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	C 2016 Mar 31	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	37	-115	18	-2	51	2	247	84	32	3	29	51	50	138	58
Working Capital - Increase/(Decrease)	-27	-255	72	11	-61	-318	-37	-90	84	140	159	6	20	-23	10
Net CF from Operating Activities	10	-370	90	9	-10	-316	210	-7	116	143	188	57	70	115	68
Capital Expenditures - Net	84	7	1	1	14	21	25	50	67	-7	2	0	7	45	-20
Net CF from Investing Activities	-52	391	-47	120	-78	52	-34	131	0	-130	-117	-60	-49	-57	-83
Dividends Paid - Cash - Total	14	24	10	3	3	2	1	-	1	-	-	1	1	2	2
Stock - Issuance/(Retirement) - Net	-	-	-	-105	-	-	-	-	-	-	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	60	3	-35	25	-31	239	-203	-131	-100	-82	-75	14	-31	20	158
Net Cash Flow from Financing Activities	43	-25	-46	-86	-34	237	-204	-131	-102	-82	-75	13	-32	17	156
Free Cash Flow to Equity	-14	-374	54	32	-55	-98	-17	-187	-50	69	112	71	33	89	247
Free Operating CF net dividend	-88	-402	79	4	-28	-340	184	-56	48	136	182	56	56	64	65
Free Operating CF	-74	-377	89	8	-26	-337	186	-56	50	136	182	57	57	66	68

Business Segment Analysis

FY End:

Mar 26

Riddhi Siddhi Gluco Biols Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Revenue / Sales

Trading Business (80.6%)₹ 190.04 CrPackaged Water Bottling (13.9%)₹ 32.72 CrWind Energy Generation (5.5%)₹ 13.09 Cr

Assets

Unallocated (75.9%)₹ 1,358.29 CrPackaged Water Bottling (20.3%)₹ 364.03 CrTrading Business (2.2%)₹ 38.50 CrWind Energy Generation (1.6%)₹ 29.50 Cr

Regional Segment Analysis

FY End:

Mar 26

Riddhi Siddhi Gluco Biols Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (100.0%)₹ 235.84 Cr

Historical Segment Analysis

Track how Riddhi Siddhi Gluco Biols Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31	2019 Mar 31	2020 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31	2019 Mar 31	2020 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Others	0	0	0	0	-	-	-	-	-	-
Wind Energy Generation	48	167	0	0	0	-	0	0	0	0
Unallocated	-	-	-	-	14	59	0	0	0	-
Packaged Water Bottling	-	-	-	-	-	-	0	0	0	0
Packaged Water Bottling	-	-	-	-	-	-	0	0	0	-

Frequently Asked Questions

What is the revenue of Riddhi Siddhi Gluco Biols Ltd.?

The latest trailing twelve month revenue of Riddhi Siddhi Gluco Biols Ltd. is ₹ 171.10 Cr, reflecting a 1-year growth of -37.97% and a 3-year CAGR of 4.38%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Riddhi Siddhi Gluco Biols Ltd.?

The latest trailing twelve month net profit (PAT) of Riddhi Siddhi Gluco Biols Ltd. is ₹ -9.49 Cr, with a 3-year earnings CAGR of -27.57%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Riddhi Siddhi Gluco Biols Ltd.?

The trailing twelve month EBITDA of Riddhi Siddhi Gluco Biols Ltd. is approximately ₹ -23.17 Cr (based on an operating margin of -13.54%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Riddhi Siddhi Gluco Biols Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Riddhi Siddhi Gluco Biols Ltd. is 18.62. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Riddhi Siddhi Gluco Biols Ltd.?

The debt-to-equity ratio of Riddhi Siddhi Gluco Biols Ltd. stands at 0.19. The interest coverage ratio is -1.16x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Riddhi Siddhi Gluco Biols Ltd.?

The estimated book value per share of Riddhi Siddhi Gluco Biols Ltd. is 2,097.36 (derived from a P/B ratio of 0.31 and market price of ₹ 650.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Riddhi Siddhi Gluco Biols Ltd.?

The trailing twelve month operating cash flow of Riddhi Siddhi Gluco Biols Ltd. is ₹ 67.90 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Riddhi Siddhi Gluco Biols Ltd. report consolidated or standalone financials?

Riddhi Siddhi Gluco Biols Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.